Anders D. Poulsen

10 Biopolis Road #05-01 Chromos
138670, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Testing the large genome constraint hypothesis in tropical rhizomatous herbs: life strategies, plant traits and habitat preferences in gingers.

Testing the large genome constraint hypothesis in tropical rhizomatous herbs: life strategies, plant traits and habitat preferences in gingers.

Journal: The Plant journal : for cell and molecular biology

Published: February 08, 2023

Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors.

Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: July 16, 2021

Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*.

Strategic Design of Catalytic Lysine-Targeting Reversible Covalent BCR-ABL Inhibitors*.

Journal: Angewandte Chemie (International ed. in English)

Published: April 20, 2021

Discovery of a Novel Mycobacterial F-ATP Synthase Inhibitor and its Potency in Combination with Diarylquinolines.

Discovery of a Novel Mycobacterial F-ATP Synthase Inhibitor and its Potency in Combination with Diarylquinolines.

Journal: Angewandte Chemie (International ed. in English)

Published: February 20, 2020

Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2.

Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2.

Journal: Journal of medicinal chemistry

Published: January 08, 2020

Correction to "Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3".

Correction to "Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3".

Journal: ACS medicinal chemistry letters

Published: August 16, 2019

Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3.

Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3.

Journal: ACS medicinal chemistry letters

Published: April 15, 2019

Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N1G37) Methyltransferase (TrmD) Inhibitors.

Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N1G37) Methyltransferase (TrmD) Inhibitors.

Journal: ACS infectious diseases

Published: January 26, 2019

Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues.

Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues.

Journal: ACS medicinal chemistry letters

Published: November 12, 2018

Intranasal administration of a stapled relaxin-3 mimetic has anxiolytic- and antidepressant-like activity in rats.

Intranasal administration of a stapled relaxin-3 mimetic has anxiolytic- and antidepressant-like activity in rats.

Journal: British journal of pharmacology

Published: September 24, 2018

Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption.

Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption.

Journal: Frontiers in microbiology

Published: September 12, 2018

Design and synthesis of potent dual inhibitors of JAK2 and HDAC based on fusing the pharmacophores of XL019 and vorinostat.

Design and synthesis of potent dual inhibitors of JAK2 and HDAC based on fusing the pharmacophores of XL019 and vorinostat.

Journal: European journal of medicinal chemistry

Published: July 11, 2018

Showing 1-12 of 53

Last Updated: 09/26/2026